InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,230.80
(
-0.15%
)
Dow Jones
39,134.76
(
0.00%
)
Brent Oil
85.02
(
0.02%
)
Bitcoin
63,486.03
(
-2.06%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jaybe

Send PM Follow Ignore
Followers 5
Posts 277
Boards Moderated 0
Alias Born 05/29/2011

jaybe

Re: None

Sunday, 01/20/2013 7:45:39 PM

Sunday, January 20, 2013 7:45:39 PM

Post# of 80490
Can you really look at this chart and doubt our future?

http://www.mycancergenome.org/content/other/molecular-medicine/targeted-therapeutics

Ariad has demonstrated activity in 11 of the 30 or so families of proven targets for tyrosine kinase inhibitors, and with only 3 molecules to boot, each targeting several indications.

All we need to round out the sweet would be a Her-2, Jak, PI3k, or VEGF target. Anyone care to venture a guess for the next molecule's target?


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up